• Bone Marrow Failure Disorders
• Amegakaryocytosis
• Aplastic Anemia (Severe)
• Blackfan-Diamond Anemia
• Congenital Cytopenia*
• Congenital Dyserythropoietic Anemia
• Dyskeratosis Congenita
• Fanconi Anemia
• Paroxysmal Nocturnal Hemoglobinuria (PNH)
• Pure Red Cell Aplasia


• Hemoblobinopathies
• Beta Thalassemia Major
• Sickle Cell Disease


• Histiocytic Disorders
• Familial Erythrophagocytic Lymphohistiocytosis
• Hemophagocytosis
• Langerhans' Cell Histiocytosis (Histiocytosis X)


• Inherited Immune System Disorders
• Chronic Granulomatous Disease
• Congenital Neutropenia
• Leukocyte Adhesion Deficiency
• Severe Combined Immunodeficiencies (SCID) including:
• Adenosine Deaminase Deficiency*
• Bare Lymphocyte Syndrome
• Chediak-Higashi Syndrome*
• Kostmann Syndrome
• Omenn Syndrome
• Purine Nucleoside Phosphorylase Deficiency
• Reticular Dysgenesis
• Wiskott-Aldrich Syndrome
• X-Linked Lymphoproliferative Disorder


• Inherited Metabolic Disorders
• Adrenoleukodystrophy
• Fucosidosis
• Gaucher Disease*
• Hunter Syndrome (MPS-II)
• Hurler Syndrome (MPS-IH)
• Krabbe Disease
• Lesch-Nyhan Syndrome
• Mannosidosis*
• Maroteaux-Lamy Syndrome (MPS-VI)
• Metachromatic Leukodystrophy
• Mucolipidosis II (I-cell Disease)*
• Neuronal Ceroid Lipofuscinosis (Batten Disease)*
• Niemann-Pick Disease*
• Sandhoff Disease*
• Sanfilippo Syndrome (MPS-III)
• Scheie Syndrome (MPS-IS)
• Sly Syndrome
• Tay Sachs*
• Wolman Disease


• Leukemias and Lymphomas
• Acute Biphenotypic Leukemia*
• Acute Lymphocytic Leukemia (ALL)
• Acute Myelogenous Leukemia (AML)
• Acute Undifferentiated Leukemia*
• Adult T Cell Leukemia/Lymphoma
• Chronic Lymphocytic Leukemia (CLL)
• Chronic Myelogenous Leukemia (CML)
• Hodgkin's Lymphoma
• Juvenile Chronic Myelogenous Leukemia (JCML)
• Juvenile Myelomonocytic Leukemia (JMML)
• Myeloid/Natural Killer (NK) Cell Precursor Acute Leukemia
• Non-Hodgkin's Lymphoma
• Polymphocytic Leukemia


• Myelodysplastic/Myeloproliferative Disorders
• Acute Myelofibrosis*
• Agnogenic Myeloid Metaplasia (Myelofibrosis)*
• Amyloidosis
• Chronic Myelomonocytic Leukemia (CMML)
• Essential Thrombocythemia*
• Polycythemia Vera*
• Refractory Anemias (RA) including:
• Refractory Anemia with Excess Blasts (RAEB)
• Refractory Anemia with Excess Blasts in Transformation (RAEB-T)
• Refractory Anemia with Ringed Sideroblasts (RARS)


• Plasma Cell Disorders
• Multiple Myeloma
• Plasma Cell Leukemia
• Waldenstrom's Macroglobulinemia
  
  
• Other Inherited Disorders
• Cartilage-Hair Hypoplasia
• Congenital Erythropoietic Porphyria (Gunther Disease)
• DiGeorge Syndrome
• Osteopetrosis


• Other Malignancies
• Brain Tumors**
• Ewing Sarcoma*
• Neuroblastoma
• Ovarian Cancer**
• Renal Cell Carcinoma**
• Rhabdomyosarcoma
• Small Cell Lung Cancer**
• Testicular Cancer**
• Thymoma (Thymic Carcinoma)


• Other
• Chronic Active Epstein Barr
• Evans Syndrome
• Multiple Sclerosis**
• Rheumatoid Arthritis**
• Systemic Lupus Erythematosus**
• Thymic Dysplasia

*Refer to www.clinicaltrials.gov for additional information
**Not routinely eligible for participation in CBR's Designated Transplant Program Source: Medical literature and www.clinicaltrials.gov

Return to top

• Diabetes
• Heart Disease
• Liver Disease
• Muscular Dystrophy
• Parkinson's Disease
• Spinal Cord Injury
• Stroke

Return to top